Detalhe da pesquisa
1.
Monoclonal antibodies specific for the capsid protein of chikungunya virus suitable for multiple applications.
J Gen Virol
; 96(Pt 3): 507-512, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25480927
2.
Neutralizing monoclonal antibodies to the E2 protein of chikungunya virus protects against disease in a mouse model.
Clin Immunol
; 149(3): 487-97, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24239837
3.
Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice.
Small
; 6(16): 1776-84, 2010 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20665754
4.
Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
mBio
; 8(1)2017 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28223458
5.
A sensitive epitope-blocking ELISA for the detection of Chikungunya virus-specific antibodies in patients.
J Virol Methods
; 222: 55-61, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26025459
6.
The Chikungunya Virus Capsid Protein Contains Linear B Cell Epitopes in the N- and C-Terminal Regions that are Dependent on an Intact C-Terminus for Antibody Recognition.
Viruses
; 7(6): 2943-64, 2015 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26061335